fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

The business case for the VTE service

Written by | 25 Sep 2021

A robust business case can be made for the VTE service and the coronavirus pandemic has further demonstrated the value of the service, according to Mr Kieron Power;… read more.

Action on overprescribing of medicines

Written by | 24 Sep 2021

Ministers are announcing action to prevent medicines being prescribed unnecessarily, following a new review led by Dr Keith Ridge CBE, Chief Pharmaceutical Officer for England. The review of… read more.

VTE pathways, clinics and prescribing

Written by | 24 Sep 2021

Patient pathways, independent prescribing by pharmacists and education of junior doctors all contribute to the effective operation of the VTE service, according to Mr Kieron Power; Lead Pharmacist… read more.

Making the VTE service work in practice

Written by | 23 Sep 2021

Recurrence of venous thrombo-embolism (VTE) may be more common than people think and 30% of people develop post thrombotic syndrome, according to Mr Kieron Power; Lead Pharmacist –… read more.

The venous thrombo-embolism service – overview

Written by | 22 Sep 2021

Specialist pharmacists are now the primary clinicians who look after patients with venous thromboembolism (VTE) at Singleton Hospital in Swansea. IMI spoke to Mr Kieron Power, Clinical Lead… read more.

EMA gives green light for 8 new medicines

Written by | 17 Jul 2021

The European Medicine Agency’s key decision-making committee on human medicines (CHMP), has recommended eight medicines for approval at its June meeting.  The Committee recommended granting a conditional marketing authorisation for Abecma… read more.

EMA reports big wins for small pharma

Written by | 16 Jul 2021

The success rate for marketing authorisation applications for small and medium-sized enterprises (SMEs) has doubled between 2016 and 2020, according to the European Medicines Agency (EMA). In 2016,… read more.

Dessicated liposome technology improves vaccine stability

Written by | 13 Jul 2021

Mountain Valley MD, Ontario, Canada The results of the first study to evaluate the stability of Trivalent Inactivated Poliovirus Vaccine (tIPV) formulated in desiccated liposomes (QuIcksometm) has yielded… read more.

Implantable piezoelectric polymer improves controlled release of drugs

Written by | 10 Jun 2021

Repeated tests showed a similar amount of drug release per activation, confirming robust control of release rate. A membrane made from threads of a polymer commonly used in… read more.

Merck Inc. at Organon investor day outlines the vision and plans for the new company

Written by | 14 May 2021

Merck Inc., hosted on 3 May an Organon management investor day meeting, to detail across women’s health, biosimilars and established brands.The new company will be launched on 3… read more.

Measuring the outcomes of iSIMPATHY

Written by | 14 May 2021

Interview and article by Christine Clark. Dr Claire Scullin explains how the iSIMPATHY project has been designed to end up with sustainable scheme to manage polypharmacy that has… read more.

How pharmacist prescribers will tackle polypharmacy

Written by | 13 May 2021

Interview and article by Christine Clark. Drs Claire Scullin and Joanne Brown describes how prescribing pharmacists will carry out in-depth medication reviews for hospital inpatients and make any… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.